Daniel Graciaa is an Infectious Disease physician affiliated with Emory University. OpenAlex indexes 44 publications with 648 citations (h-index 11); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
550 Peachtree St NE
Atlanta, GA 303082212
Telephone
404-686-8114Provider last certified this registry record 30 May 2025.
Clinical trials
- Revealing Protective Immunity to Influenza Using Systems Immunology
Sponsor: Emory University
- Systems Biological Assessment of Statin Effect on Vaccine Responses
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
55.3%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor20.1%Triumeq57%Descovy31%Abacavir-Lamivudine12%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor16.2%Tivicay100%Part D<11 patients+ 4 more classes in this area
Cardiovascular
27.9%Statin9.6%Atorvastatin Calcium70%Pravastatin Sodium30%Part D<11 patientsACE inhibitor8.2%Lisinopril74%Lisinopril-Hydrochlorothiazide26%Part D<11 patients+ 3 more classes in this area
Genitourinary & hormones
4.6%alpha-Adrenergic Blocker2.3%Alfuzosin Hcl Er100%Part D<11 patients5-alpha Reductase Inhibitor2.3%Finasteride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Guyton, MD
Emory University
Keith Delman, MD
Emory University
Paolo Raggi, MD
Emory University
Monica Farley, MD
Emory University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”